177 related articles for article (PubMed ID: 18605231)
1. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells.
Xu FY; Queen G; Brandes L; Hatch GM
Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231
[TBL] [Abstract][Full Text] [Related]
2. N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene), a chemopotentiating agent with hormetic effects on DNA synthesis in vitro, may improve survival in patients with metastatic breast cancer.
Brandes LJ
Hum Exp Toxicol; 2008 Feb; 27(2):143-7. PubMed ID: 18480139
[TBL] [Abstract][Full Text] [Related]
3. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
[TBL] [Abstract][Full Text] [Related]
4. Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.
Reyno L; Seymour L; Tu D; Dent S; Gelmon K; Walley B; Pluzanska A; Gorbunova V; Garin A; Jassem J; Pienkowski T; Dancey J; Pearce L; MacNeil M; Marlin S; Lebwohl D; Voi M; Pritchard K;
J Clin Oncol; 2004 Jan; 22(2):269-76. PubMed ID: 14722035
[TBL] [Abstract][Full Text] [Related]
5. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
Brandes LJ; Queen GM; LaBella FS
Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene.
Ferguson PJ; Brisson AR; Koropatnick J; Vincent MD
Cancer Lett; 2009 Feb; 274(2):279-89. PubMed ID: 18986763
[TBL] [Abstract][Full Text] [Related]
7. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen dioxide-induced phosphatidylserine biosynthesis and subcellular translocation in cultured pulmonary artery endothelial cells.
Li YD; Patel JM; Block ER
Toxicol Appl Pharmacol; 1994 Nov; 129(1):114-20. PubMed ID: 7974483
[TBL] [Abstract][Full Text] [Related]
9. Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents.
Brandes LJ; Simons KJ; Bracken SP; Warrington RC
J Clin Oncol; 1994 Jun; 12(6):1281-90. PubMed ID: 8201390
[TBL] [Abstract][Full Text] [Related]
10. A tamoxifen derivative, N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine, selectively targets P-glycoprotein-positive multidrug resistant Chinese hamster cells.
Georges E; Lian J; Laberge R
Biochem Pharmacol; 2014 Jul; 90(2):107-14. PubMed ID: 24821111
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada clinical trials group study.
Khoo K; Brandes L; Reyno L; Arnold A; Dent S; Vandenberg T; Lebwohl D; Fisher B; Eisenhauer E
J Clin Oncol; 1999 Nov; 17(11):3431-7. PubMed ID: 10550138
[TBL] [Abstract][Full Text] [Related]
12. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
Brandes LJ; LaBella FS; Warrington RC
J Natl Cancer Inst; 1991 Sep; 83(18):1329-36. PubMed ID: 1886159
[TBL] [Abstract][Full Text] [Related]
13. The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethamine.HCL, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study.
Brandes LJ; Bracken SP
Breast Cancer Res Treat; 1998 May; 49(1):61-8. PubMed ID: 9694612
[TBL] [Abstract][Full Text] [Related]
14. Effects of docosahexaenoic and arachidonic acids on the synthesis and distribution of aminophospholipids during neuronal differentiation of PC12 cells.
Ikemoto A; Kobayashi T; Emoto K; Umeda M; Watanabe S; Okuyama H
Arch Biochem Biophys; 1999 Apr; 364(1):67-74. PubMed ID: 10087166
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
Kudoh K; Kikuchi Y; Hiramatsu H; Hirata J; Yamamoto K; Kita T; Nagata I
Eur J Cancer; 1997 Jan; 33(1):122-8. PubMed ID: 9071911
[TBL] [Abstract][Full Text] [Related]
16. Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.
Hiramatsu H; Kikuchi Y; Kudoh K; Kita T; Tode T; Nagata I
Jpn J Cancer Res; 1997 Oct; 88(10):1003-8. PubMed ID: 9414663
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
[TBL] [Abstract][Full Text] [Related]
18. Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line.
Pohl A; Lage H; Müller P; Pomorski T; Herrmann A
Biochem J; 2002 Jul; 365(Pt 1):259-68. PubMed ID: 12071854
[TBL] [Abstract][Full Text] [Related]
19. Validation of an in vitro screen for phospholipidosis using a high-content biology platform.
Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ
Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016
[TBL] [Abstract][Full Text] [Related]
20. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
